|Last Price||Today's Change||52-Week Range||Trading Volume|
|65.86||0.51 (+0.78%)||46.30 - 69.20||9.4 million (Above Avg)|
Market data as of 4:00PM 04/20/15. Quotes are delayed by at least 15 min.
New SU2C-American Cancer Society Lung Cancer Dream Team Announced
04/20/2015 10:00 AM ET
First Randomized Study Evaluating Opdivo (nivolumab)+Yervoy (ipilimumab) Regimen Demonstrates Superior Efficacy Versus Yervoy Alone in Patients with Previously Untreated Advanced Melanoma
04/20/2015 8:30 AM ET